Can-Fite BioPharma Ltd. financial data

Symbol
CANF on NYSE
Location
26 Ben Gurion Street, Ramat Gan, Israel
Fiscal year end
December 31
Latest financial report
20-F - Q4 2024 - Apr 14, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.98B shares +119%
Common Stock, Shares, Outstanding 3.97B shares +137%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.45M USD +36.8%
Cash, Cash Equivalents, and Short-term Investments 7.88M USD -11.5%
Assets, Current 7.62M USD +30.8%
Property, Plant and Equipment, Net 5K USD -84.4%
Operating Lease, Right-of-Use Asset 91K USD +46.8%
Assets 7.72M USD +30.4%
Employee-related Liabilities, Current 675K USD -2.74%
Accrued Liabilities, Current 301K USD +20.4%
Contract with Customer, Liability, Current 405K USD -36.3%
Liabilities, Current 2.12M USD +6.69%
Contract with Customer, Liability, Noncurrent 1.38M USD -3.62%
Operating Lease, Liability, Noncurrent 33K USD +57.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.13M USD 0%
Retained Earnings (Accumulated Deficit) -171M USD -5.42%
Stockholders' Equity Attributable to Parent 4.18M USD +68.8%
Liabilities and Equity 7.72M USD +30.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 20B shares +300%
Common Stock, Shares, Issued 3.97B shares +137%
Common Stock, Par or Stated Value Per Share 0.25 ILS/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.45M USD +36.8%
Deferred Tax Assets, Valuation Allowance 28.1M USD +5.24%
Deferred Tax Assets, Gross 28.1M USD +5.24%
Operating Lease, Liability 104K USD +160%
Lessee, Operating Lease, Liability, to be Paid 133K USD +217%
Property, Plant and Equipment, Gross 79K USD -72.9%
Operating Lease, Liability, Current 57K USD +58.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 52K USD +271%
Lessee, Operating Lease, Liability, to be Paid, Year One 52K USD +108%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 29K USD +1350%
Lessee, Operating Lease, Liability, to be Paid, Year Three 29K USD +867%
Deferred Tax Assets, Operating Loss Carryforwards 27M USD +5.44%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 164M USD +1.85%